APA (7th ed.) Citation

Miyashita, N., Nakamori, Y., Ogata, M., Fukuda, N., Yamura, A., Ishiura, Y., & Ito, T. (2023, May). Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections. Viruses.

Chicago Style (17th ed.) Citation

Miyashita, Naoyuki, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, and Tomoki Ito. "Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections." Viruses May. 2023.

MLA (9th ed.) Citation

Miyashita, Naoyuki, et al. "Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections." Viruses, May. 2023.